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Factors associated with serum CA19-9 levels
among healthy children: a cross-sectional study
Sayo Kawai1*†, Sueli M Oba-Shinjo2, Lucy S Ito3, Miyuki Uno2, Suely K N Marie2 and Nobuyuki Hamajima1†
Abstract
Background: CA19-9 is a tumor marker mainly used for biliary tract, pancreas and colorectum. Since the marker
applies usually for adults, the normal range of serum CA19-9 among children has been rarely reported. This is the
first study reporting the distribution of serum CA19-9 levels among cancer-free children as well as their parents,
taking into account the Lewis and secretor gene polymorphism and physical growth.
Methods: Study subjects were 972 apparently healthy Japanese Brazilians including 476 children aged from 1 to 19
years.
Results: The comparisons in five-year age groups demonstrated that the mean values of serum CA19-9 was lower
in the boys than in the girls, and higher in younger age groups; 22.5 U/ml for 1–4 year-old (n=13), 17.4 U/ml for 5–
9 year-old (n=36), 15.5 U/ml for 10–14 year-old (n=96) and 10.2 U/ml for 15–19 year-old (n=74) in boys, and 25.3 U/
ml (n=11), 27.1 U/ml (n=50), 17.7 U/ml (n=105) and 13.5 U/ml (n=59) in girls, respectively. The difference in those
geometric means was statistically significant among four age groups (p=0.006, ANOVA adjusted for sex). After Lewis
and secretor genotypes, which are definitive factors of serum CA19-9, were taken into account, geometric mean of
serum CA19-9 was associated with any of BMI (p<0.001), height (p<0.001) and weight (p<0.001) among children
excluding those with le/le genotype. The associations were still significant when age was adjusted.
Conclusions: Serum CA19-9 values were higher among children than among adults, and influenced by sex, height,
weight, and BMI even after the adjustment for age as well as Le and Se genotypes.
Keywords: CA19-9, Healthy children, BMI, Lewis and secretor gene polymorphisms
Background
CA19-9 is a blood group antigen-related marker for cancer
screening and a prognostic factor during treatment [1].
Currently, serum CA19-9 is regarded as the most sensitive
and specific marker for the diagnosis and follow-up of
pancreatic cancer. The sensitivity of the test to detect
pancreatic cancer was 73.3% with 37 U/ml as the cut-
off value, the specificity was 87.0%, and the diagnostic
accuracy was 60.3% [2]. CA19-9 is also raised in biliary
tract [3], colorectum [1,4] and ovarian [5] malignan-
cies. Increased levels of serum CA19-9 can also occur
in hydronephrosis [6], and Hashimoto’s Thyroiditis [7].
Since the assay for CA19-9 is using the antibody
(1116-NS-19-9) that recognizes the carbohydrate
structure sialylated Lewis a (sialyl-Lea) structure [8],
Lewis phenotype influences the CA19-9 concentration
in serum. Two independent genes, Lewis gene (Le allele or
le allele) and secretor gene (Se allele or se allele), determine
the Lewis phenotype [9]. In those with no enzyme activity
genotype (le/le) of Lewis (Le) gene, serum CA19-9 values
are negative (<1.0 U/ml), while no enzyme activity geno-
type (se/se) of secretor (Se) gene is considered to have an
association with high serum CA19-9 levels. In Japanese,
the distinction of le from Le was practically possible for
genotyping T59G polymorphism (59T for Le and 59G for
le). For Se gene, A385T (sej) and pseudogene (se5) were
used for the detection of se alleles [10]. Our previous study
showed the geometric mean of serum CA19-9 was signifi-
cantly associated with current smoking among adults,
independently of Le and Se genotypes [11]. However, since
the tumor marker usually applies for adults, the above-
mentioned studies were all performed with adult subjects,
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and there were few reports about the distribution of serum
CA19-9 values of children.
To our knowledge, there were only three case–control
studies on the distribution, so far. The first study was aimed
to establish the reference values of tumor makers including
CA19-9 for pediatric malignant diseases. They reported the
distribution of serum CA19-9 concentration in 52 healthy
children collected for a nutritional study aged 1 to 17 years
[12]. Another study reported the mean values of serum
CA19-9 among 30 pediatric outpatients without blood dis-
eases as a control group compared with a 5-year-old patient
of malignant lymphoma [13]. The other study reported that
the mean values of serum CA19-9 among 27 healthy boys
and girls whose mean age was 30.1 months, as a control
group for 27 patients with unilateral ureteropelvic junction
obstruction aged 0.5 to 98 months [14].
In order to make an accurate diagnosis or prognosis of
disorders using serum CA19-9 for pediatric patients, it is
important to know about the normal values of CA19-9
among children. In this study, we measured the serum
CA19-9 values of children and adolescents aged less than
20 years among cancer-free Japanese-Brazilians, as well as
those of their parents. The association between serum
CA19-9 and candidate factors such as age, sex, weight,
height, and body mass index (BMI, weight in kilogram
divided by height squared in meter) were also examined.
Methods
Study subjects
The subjects of this study were apparently healthy family
volunteers, who were enrolled for a study on Helicobacter
pylori infection through Japanese-Brazilian societies in São
Paulo in 2002 [15]. The family units were defined as
husband, wife, and one or more children aged from 1 to 19
years and they all lived in the same household. Written
informed consent was obtained from all the participants. In
case of children, the parents signed the consent form
instead of their children providing consent. The collection
of lifestyle data and blood was conducted after the
consent was obtained. Among the participated 1,037
Japanese Brazilians, 1,024 samples were available for
CA19-9 measurement. Excluding the subjects lacking
of one or more items of data under study, and one
subject with more than 250 U/ml of serum CA19-9
who was on suspicion of carrying some diseases or
disorders, 972 subjects (496 adults and 476 children)
were applied to the present study. This study was
approved by Ethics Committees of Nagoya University
School of Medicine (approval number 1112).
Quantitative analysis of serum CA19-9 and genotyping
A 10-ml sample of venous blood was obtained from each
participant. The blood samples were centrifuged and frozen
at -20°C according to an identical protocol, then they were
transferred to Japan in 2002 and stored at -80°C thereafter.
The serum concentration of CA19-9 was measured by
SRL Inc., Tokyo Japan, in 2009 with chemiluminescent
enzyme immunoassay (CLEIA) (upper limit of normal
range, 37 U/ml). DNAs were extracted from the blood by a
salting-out method and utilized for polymorphism analysis.
The Le and Se gene polymorphisms were genotyped in
2009 by polymerase chain reaction with confronting two-
pair primers (PCR-CTPP) [16]. The detailed primer sets
and PCR conditions were shown in our previous study [17].
Statistical analysis
Information about age, sex, smoking and alcohol drinking
habit was self-reported and BMI was calculated from
height and weight. Hardy-Weinberg equilibrium was
tested for the Le and Se genotypes. Since the distribution
of serum CA19-9 values followed lognormal, geometric
means were tested by analysis of variance (ANOVA).
When geometric means were calculated, the detectable
limit (1 U/ml) was used for the below limit. Box and whis-
ker plot in figures indicates lower adjacent value (the lo-
west datum still within 1.5 interquartile range of the lower
quartile), 25th percentile (lower quartile), 50th percentile
(median), 75th percentile (upper quartile), and upper adja-
cent value (the highest datum still within 1.5 interquartile
range of upper quartile). All calculations were performed
with the Stata 9 computer program (StataCorp, College
Station, TX, USA).
Results
Background characteristics and genotype frequencies
Table 1 shows the characteristics of the subjects according
to sex. The data indicated that the mean value of serum
CA19-9 was higher in females than males. There were no
smokers or alcohol drinkers among the 476 children aged
less than 20 years. Among their parents, current smokers
were 22.6% in males and 9.4% in females, and alcohol drin-
kers were 62.7% and 25.4%, respectively.
Allele frequency of Le T59G polymorphism was 69.4%
for Le (59T) and 30.6% for le (59G), with 475 (48.9%)
subjects for Le/Le, 400 (41.1%) for Le/le and 97 (10.0%)
for le/le. On Se A385T polymorphism and pseudogene,
allele frequencies were 52.1% for A (Se), 42.2% for T (sej)
and 5.7% for pseudogene (se5), with 259 (26.7%) for Se/
Se, 495 (50.9%) for Se/se and 218 (22.4%) for se/se, where
sej and se5 were categorized into one group as “se”.
There was only one subject with homozygous for se5
allele (se5/se5) in this dataset. The genotype frequencies
for Le and Se were in Hardy-Weinberg equilibrium
(χ2=0.89, p=0.34 and χ2=0.40, p=0.53, respectively).
Table 2 shows Le and Se genotype frequencies of the
children and their parents.
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Serum CA19-9 and ages of subjects
The distribution of serum CA19-9 by age is shown in
Figure 1. The comparison in five-year age groups
demonstrated that the geometric mean of serum
CA19-9 was higher in younger age groups; 22.5 U/ml
for 1–4 year-old (n=13), 17.4 U/ml for 5–9 year-old
(n=36), 15.5 U/ml for 10–14 year-old (n=96) and 10.2
U/ml for 15–19 year-old (n=74) in boys, and 25.3 U/ml
(n=11), 27.1 U/ml (n=50), 17.7 U/ml (n=105) and 13.5
U/ml (n=59) in girls, respectively. The difference in
those geometric means was statistically significant
among four age groups (p=0.006, ANOVA adjusted for
sex). Regression analysis also indicated that age was sig-
nificantly associated with logarithm of serum CA19-9
levels (β,−0.022, p<0.001). This tendency was not observed
among the parents (p=0.38, ANOVA adjusted for sex).
The significant association between serum CA19-9 and
sex was also observed only among children (p=0.004
among the children and p=0.29 among the parents,
ANOVA adjusted for four age groups).
Serum CA19-9 according to genotypes and generations
Among the children aged less than 20 years, geometric
mean for CA19-9 was 34.1 U/ml for Le/Le & se/se, 32.6
U/ml for Le/le & se/se, 11.6 U/ml for Le/Le & Se/se, 8.7
U/ml for Le/Le & Se/Se, 8.3 U/ml for Le/le & Se/se, 6.4
Table 1 Characteristics of study subjects
Characteristics Children aged less
than 20 years
Adults (Parents)
Boys Girls Men Women
(N=251) (N=225) (N=252) (N=244)
Age in years
Mean (Range) 11.5 (1–19) 11.7 (1–19) 45.8 (25–66) 42.8 (22–69)
CA19-9
Mean* (±S.D.) 14.8
(±19.4)
19.1
(±21.4)
9.5
(±9.3)
11.9
(±11.9)
Range 1-136 1-128 1–89.8 1–87.2
Height (cm)
Mean (Range) 147.7
(72–185)
143.8
(60–172)
167.9
(150–190)
156.0
(140–173)
Weight (kg)
Mean (Range) 44.6
(10–100)
39.6
(10–83)
70.6
(35–105)
56.2
(38–90)
BMI (kg/m2)
Mean (Range) 19.4
(6.1-35.0)
18.6
(5.9-33.3)
25.0
(15.6-36.3)
23.1
(16.9-37.8)
Smoking
Current smokers 0 0 57 (22.6%) 23 (9.4%)
Non-current smokers 0 0 195 (77.4%) 221 (90.6%)
Alcohol
Current drinkers 0 0 158 (62.7%) 62 (25.4%)
Non-current drinkers 0 0 94 (37.3%) 182 (74.6%)
NOTE. BMI: body mass index. *Arithmetic mean.
Table 2 Genotype frequencies for Lewis and secretor
polymorphisms
Characteristics Children Parents All subjects
Lewis T59G
Le/Le (TT) 229 (48.1%) 246 (49.6%) 475 (48.9%)
Le/le (TG) 199 (41.8%) 201 (40.5%) 400 (41.1%)
Le/le (GG) 48 (10.1%) 49 (9.9%) 97 (10.0%)
secretor A385T & pseudogene*
Se/Se 121 (25.4%) 138 (27.8%) 259 (26.7%)
Se/se 251 (52.7%) 244 (49.2%) 495 (50.9%)
se/se 104 (21.9%) 114 (23.0%) 218 (22.4%)
*sej (385T) and se5 (pseudogene) are categorized into one group as “se”.
Figure 1 Geometric mean of serum CA19-9 for 5-year age
groups according to Se genotype. Shift of the geometric mean of
serum CA19-9 for each 5-year age groups according to Se genotype
excluding those with le/le genotype.
Table 3 Geometric means of serum CA19-9 (U/ml) for
each genotype among the children and their parents
Genotype Children (N) Parents (N) p-valueb
Le/Le & se/se 34.1 (37) 20.9 (57) < 0.0001
Le/le & se/se 32.6 (52) 21.0 (40) 0.005
Le/Le & Se/se 11.6 (133) 8.3 (115) < 0.0001
Le/Le & Se/Se 8.7 (59) 6.8 (74) 0.03
Le/le & Se/se 8.3 (97) 6.3 (109) 0.001
Le/le & Se/Se 6.4 (50) 5.5 (52) 0.36
le/le & se/se 1a (15) 1a (17) n/a
le/le & Se/se 1a (21) 1.2 (20) 0.35
le/le & Se/Se 1a (12) 1.0 (12) 0.29
Total 9.3 (476) 7.1 (496) < 0.0001
aAll subjects in the groups indicated below the detection limit (1 U/ml)
bCalculated by ANOVA adjusted for sex.
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U/ml for Le/le & Se/Se, and below the detection limit
(1 U/ml) for le/le & se/se, le/le & Se/se and le/le & Se/Se.
Among their parents, the mean for CA19-9 values was
20.9 U/ml, 21.0 U/ml, 8.3 U/ml, 6.8 U/ml, 6.3 U/ml, 5.5
U/ml, below the detection limit, 1.2 U/ml and 1.0 U/ml,
respectively. The difference of the geometric mean
values between the children and the parents was statisti-
cally significant (p<0.0001, ANOVA adjusted for sex)
(Table 3 and Figure 2).
Effects of height, weight, and BMI on serum CA19-9
among the children
Among those with Le/Le or Le/le (the subjects excluding
those with le/le), it was found that children aged less
than 20 years with high BMI (20 kg/m2 and more) indi-
cated lower values of serum CA19-9 (p=0.007, ANOVA
adjusted for age groups, sex and Se genotype) (Table 4).
Among the same subjects, the regression analysis indi-
cated that logarithm of CA19-9 was significantly
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Figure 2 Distribution of serum CA19-9 according to Le and Se genotypes.
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associated with any of BMI (β, −0.018, p<0.001), height
(β, −0.005, p<0.001) and weight (β, −0.006, p<0.001)
adjusted for sex and Se genotype, while the associations
were not observed among their parents (p=0.31 for BMI,
p=0.17 for height, and p=0.71 for weight). The associa-
tions among the children were still significant when they
further adjusted for age (p=0.022 for BMI, p=0.013 for
height, and p=0.002 for weight) (Table 5).
Discussion
There were few reports on serum CA19-9 values of chil-
dren. Except for the case–control studies with a limited
number of controls, this is the first report of the distri-
bution of serum CA19-9 values of subjects aged less
than 20 years. The new finding is that the children in
early years indicated high serum CA19-9 values and it
decreases along with their maturation.
Since Le and Se genotypes influence serum CA19-9
levels, the genotypes were taken into account for the
present study. The allele frequencies were similar to
those of the previous studies for Japanese population
[10,18]. In Le gene, le/le genotype has no enzyme activ-
ity, which results in no synthesis of CA19-9 even among
cancer patients. In Se gene, 385T (sej) and pseudogene
(se5) are no activity alleles, so that sej/sej, sej/se5, and
se5/se5 genotypes are concerned with over synthesis of
CA19-9. This study reported Le and Se genotype fre-
quencies and the geometric mean values of serum
CA19-9 for each combination of these genotypes. The
combination of the full enzyme activity genotype of Le
gene (Le/Le or Le/le) and no enzyme activity genotype of
Se gene (se/se) indicated the highest mean value of
serum CA19-9 among both of the generations.
In case of Caucasians, although the reported poly-
morphisms of Le and Se genes are partly different from
Japanese, the alleles without enzyme activity are
observed. The common haplotypes without enzyme ac-
tivity are 59G & 508A (le1) and 59G & 1067A (le2) in
Japanese, and 59G & 314T in Caucasians [19]. Any of
508A, 1067A and 314T alleles of Le gene could lead to
lose the Lewis enzyme activity. Concerning Se gene,
common alleles without enzyme activity are sej and se5
among Japanese, and 428A of G428A polymorphism in
Caucasians. Although there was no previous information
about the frequencies of Le, Se genotypes among Japa-
nese-Brazilians, their genetic background is basically the
same and this study showed the similar frequencies to
the previous Japanese population. Since there are no
substantial differences in frequency of no activity alleles
between Caucasians and Japanese, the consequence of
this study would be applicable to any population groups.
The present study showed that serum CA19-9 levels
were significantly higher in children than in their par-
ents, and it seemed to be associated with body constitu-
tions or maturity. The mean serum CA19-9 value of the
parents of children whose CA19-9 values were higher
than 37 U/ml was 12.3 U/ml and those of the rest of
parents was 10.4 U/ml; the difference was not statisti-
cally significant (p=0.19, ANOVA adjusted for age
groups, sex and Le and Se genotypes). In this study, the
youngest group indicated the highest mean value of
serum CA19-9 in five-year age groups of the children.
The regression analysis showed that younger age and
high serum CA19-9 level were significantly associated
among the children (p<0.001). This result was inconsist-
ent with the study in Finland about 20 years ago, which
was concluded that the age of individuals did not have
any influence on the concentrations of the CA19-9 mar-
ker [12]. However, they also reported that the range of
serum CA19-9 levels in healthy children were clearly
wider than in adults and there were no detailed informa-
tion about the mean values of each age groups.
At the beginning, we thought the feasible candidate
for explaining the association between younger age and
high serum CA19-9 was BMI. ANOVA demonstrated
that children with high BMI (20 kg/m2 and more) indi-
cated significantly lower values of serum CA19-9
(p=0.007). Then we conducted the regression analysis
Table 4 Geometric means of serum CA19-9 for body mass
index (BMI) among the children excluding those with le/
le genotype
N Geometric mean (U/ml) F* p-value
BMI (kg/m2) < 20 275 13.6
BMI (kg/m2) ≥ 20 153 9.6 7.31 0.007
*Calculated by ANOVA adjusted for age group, sex and Se genotype.
Table 5 Coefficients (β) of BMI, height and weight,
estimated by regression analysis for the logarithm of
CA19-9 among the subjects excluding those with le/le
genotype
β (p-value) β (p-value)
adjusted for sex & Se
genotype
adjusted for sex, Se genotype
& agea
Children
BMI −0.018 (<0.001) −0.010 (0.022)
Height −0.005 (<0.001) −0.003 (0.013)
Weight −0.006 (<0.001) −0.005 (0.002)
Parentsb
BMI 0.004 (0.31) 0.003 (0.39)
Height −0.003 (0.17) −0.002 (0.25)
Weight 0.001 (0.71) 0.001 (0.70)
aFive-year age groups.
bDrinking and smoking statuses are added as adjusting factors.
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with BMI, as well as height and weight, to test the hy-
pothesis that the tendency could be associated with body
constitutions. Any association with BMI, height and
weight was significant, and the associations were still
significant when they adjusted for age. Therefore, BMI
seems to be one of the factors to determine the serum
CA19-9 levels independently of ageing. Recently, one
study reported that obese men had lower tumor marker
levels, including CA19-9, than men in normal weight.
They considered that hemodilution from increased
plasma volume was the main reason of the observed de-
crease in tumor marker concentration in men with a
high BMI [20]. However, decreasing of serum CA19-9
was not the results for obese among the present study
subjects, there could be other unknown factors we
should focus on.
Conclusions
Serum CA19-9 values were higher among children than
among adults, and influenced by sex, height, weight, and
BMI even after the adjustment for age as well as Le and
Se genotypes. Further investigation would be required to
elucidate the mechanism of this phenomenon.
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